Brief: Mankind Pharma and Astrazeneca Pharma India Enter Exclusive Distribution Agreement
March 11 (Reuters) - Mankind Pharma Ltd MNKI.NS :
* ASTRAZENECA PHARMA INDIA, CO PARTNER TO ACCELERATE ACCESS TO ASTHMA
MEDICINE FOR
PATIENTS IN INDIA
* ENTERED AGREEMENT FOR EXCLUSIVE DISTRIBUTION OF ASTRAZENECA’S SYMBICORT
BRAND IN
INDIA
* ASTRAZENECA TO RETAIN INTELLECTUAL PROPERTY RIGHTS TO BUDESONIDE AND
FORMOTEROL
FUMARATE DIHYDRATE
* ASTRAZENECA TO CONTINUE TO BE MARKETING AUTHORISATION HOLDER AND IMPORT
LICENSE
Further company coverage: MNKI.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication